By Diane Alter, Contributing Writer, Money Morning - • Print | Email
VRX stock has been on a huge rally recently.
After gaining nearly 27% last month, shares of Valeant stock are up another 7% so far this week.
But there's one reason we're still staying away from VRX stock in 2016...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
The VRX stock price rebounded 10% this week after announcing it has named drug-industry veteran Joseph Papa its next chairman and CEO as it attempts to restore investor confidence.
Papa comes with vast industry experience, but his appointment may be too little too late for Valeant.
Here's why we remain bearish on the VRX stock price...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
Down 67% year to date, Valeant stock has even further to fall.
In fact, Money Morning Global Credit Strategist Michael E. Lewitt says the Valeant stock price has no real value. He even calls for the firm's bankruptcy in the not-so-distant future.
Here's what you need to know...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
The VRX stock price is falling again today following new default warnings for Valeant Pharmaceuticals.
Valeant shares are now down 70% year to date, and we still think they have even more room to fall.
Here's what you need to know about the VRX stock price today, and what's next for the company.
By Michael E. Lewitt, Global Credit Strategist, Money Morning • @MichaelELewitt - • Print | Email
Every time investors think Valeant Pharmaceuticals has hit rock bottom, the company finds a way to prove them wrong.
But if they'd kept an eye out for these signs, they could have bypassed this entire train wreck.
Watch for these signals to avoid bad investments like Valeant...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
It has been an incredibly volatile day for the Valeant stock price. VRX stock jumped more than 15% to $31.59 this morning (Monday) after the pharmaceutical giant announced sweeping changes to its board.
Valeant Pharmaceutics Internationa Inc. (NYSE: VRX) shares were briefly halted after the news broke. When trading resumed, Valeant stock plunged. Ten minutes into today's session, the Valeant stock price was down 1% to a new 52-week low of $26.
Here's what is next for Valeant stock in 2016...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
The Valeant stock price has crashed 88% over the last six months, and the stock shows no sign of recovering.
And while many investors were crushed by the loss — including famed activist Bill Ackman, who reportedly lost $1 billion on the stock – our readers made a profit of 700%.
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
The Valeant stock price crashed nearly 39% today (Tuesday) to $40.00 after the company reported dismal earnings and weak guidance for 2016.
By Michael E. Lewitt, Global Credit Strategist, Money Morning • @MichaelELewitt - • Print | Email
While half the trick of investing is figuring out what the consensus thinks, the wisdom of crowds is a myth when it comes to the markets.
Case in point, Valeant Pharmaceuticals has cratered since October 2015, but many investors cling to the belief that the company's problems will be solved.
Some hedge funds have (or had until the stock collapsed) as much as 20% to 30% of their capital in the company, which is extraordinarily reckless.
But it's all in the numbers. The masses are missing these figures, but you don't have to...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
The Valeant stock price is in free fall. Valeant stock tumbled another 8% to $59.88 today (Tuesday) after crashing 18% Monday following reports that the beleaguered company is under investigation by the U.S. Securities and Exchange Commission (SEC).
